Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30058051HIVENSG00000151577.14protein_codingDRD3NoNo1814A1A4V4
E9PCM4
P35462
X5D2G4
TVIS20057150HPVENSG00000151577.14protein_codingDRD3NoNo1814A1A4V4
E9PCM4
P35462
X5D2G4
TVIS20057354HPVENSG00000151577.14protein_codingDRD3NoNo1814A1A4V4
E9PCM4
P35462
X5D2G4
TVIS20040604HPVENSG00000151577.14protein_codingDRD3NoNo1814A1A4V4
E9PCM4
P35462
X5D2G4
TVIS44006680HTLV-1ENSG00000151577.14protein_codingDRD3NoNo1814A1A4V4
E9PCM4
P35462
X5D2G4
TCGA Plot Options
Drug Information
GeneDRD3
DrugBank IDDB09014
Drug NameCaptodiame
Target IDBE0000581
UniProt IDP35462
Regulation Typeagonist
PubMed IDs23863923
CitationsRing RM, Regan CM: Captodiamine, a putative antidepressant, enhances hypothalamic BDNF expression in vivo by synergistic 5-HT2c receptor antagonism and sigma-1 receptor agonism. J Psychopharmacol. 2013 Oct;27(10):930-9. doi: 10.1177/0269881113497614. Epub 2013 Jul 17.
GroupsExperimental
Direct ClassificationDiphenylmethanes
SMILESCCCCSC1=CC=C(C=C1)C(SCCN(C)C)C1=CC=CC=C1
Pathways
PharmGKB
ChEMBLCHEMBL2110809